Literature DB >> 31251836

Picroside II Protects SH-SY5Y Cells From Autophagy and Apoptosis Following Oxygen Glucose Deprivation/Reoxygen Injury by Inhibiting JNK Signal Pathway.

Tingting Wang1, Lin Zhu1, Hongling Liu2, Guoyi Yu3, Yunliang Guo1.   

Abstract

To explore the neuroprotective effect of picroside (Picr) II on C-Jun NH2-terminal kinase (JNK) signal pathway after oxygen glucose deprivation/reoxygen (OGD/R) in SH-SY5Y cells. In vitro, SH-SY5Y cells were used to establish the OGD/R model, which was divided into the control group, model group, Picr group, and SP600125 (SP) group. Cellular viability was measured by CCK8. Cytotoxicity was assessed with LDH assay kit. Ad-GFP-mRFP-LC3 was used to monitor autophagosome and autolysosome. Apoptoic cells were detected by Annexin V-FITC/PI apoptosis detection kit. The expressions of phospho-JNK and phospho-c-Jun were determined by western blot (WB) and immunofluorescence. The expressions of phospho-MKK4, phospho-Bcl-2, Bax, Beclin-1, and LC3 I/II were determined by WB. In the control group, only limited apoptosis and autophagy was observed, and the expression of associated proteins was very low. After OGD/R, the cellular viability of SH-SY5Y cells was reduced, whereas the cytotoxicity, apoptosis, and autophagy were increased, accompanied with an increase of phospho-MKK4, phospho-JNK, phospho-c-Jun, phospho-Bcl-2, LC3 II, Beclin-1, and Bax. During the reoxygen, treatment with Picr II or SP600125 could strengthen the cellular viability of SH-SY5Y cells, but repress the cytotoxicity, apoptosis, autophagy, and the expressions of associated protein. OGD/R could induce apoptosis and autophagy of SH-SY5Y cells by activating JNK signal pathway. Picr II could protect SH-SY5Y cells from autophagy and apoptosis following OGD/R by inhibiting JNK signal pathway. Anat Rec, 302:2245-2254, 2019.
© 2019 American Association for Anatomy. © 2019 American Association for Anatomy.

Entities:  

Keywords:  JNK; apoptosis; autophagy; oxygen glucose deprivation/reoxygen; picroside II

Year:  2019        PMID: 31251836     DOI: 10.1002/ar.24214

Source DB:  PubMed          Journal:  Anat Rec (Hoboken)        ISSN: 1932-8486            Impact factor:   2.064


  4 in total

1.  Artemisinin protects against cerebral ischemia and reperfusion injury via inhibiting the NF-κB pathway.

Authors:  Hui Ji; Haifeng Jin; Guangwei Li; Li Jin; Xiaoxu Ren; Ying Lv; Yuchun Wang
Journal:  Open Med (Wars)       Date:  2022-05-11

2.  Simultaneous tracking of autophagy and oxidative stress during stroke with an ICT-TBET integrated ratiometric two-photon platform.

Authors:  Wei Hu; Taotao Qiang; Li Chai; Tianyu Liang; Longfang Ren; Fei Cheng; Chunya Li; Tony D James
Journal:  Chem Sci       Date:  2022-04-21       Impact factor: 9.969

3.  Network Pharmacology and Bioinformatics Methods Reveal the Mechanism of Berberine in the Treatment of Ischaemic Stroke.

Authors:  Ke Song; Yikun Sun; Haoqi Liu; Yuanyuan Li; Na An; Liqin Wang; Hanlai Zhang; Fan Yang; Yanwei Xing; Yonghong Gao
Journal:  Evid Based Complement Alternat Med       Date:  2022-06-29       Impact factor: 2.650

4.  Dexmedetomidine improves oxygen-glucose deprivation/reoxygenation (OGD/R) -induced neurological injury through regulating SNHG11/miR-324-3p/VEGFA axis.

Authors:  Yujie Chen; Zhiying Fan; Qingwei Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.